Home > Boards > US OTC > Biotechs >

Galectin Therapeutics Inc. (GALT)

GALT RSS Feed
Add GALT Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator 123tom
Search This Board:
Last Post: 7/24/2014 10:56:48 AM - Followers: 37 - Board type: Free - Posts Today: 1

Galectin Therapeutics is a biotechnology company focused on discovery and development. We apply our leadership in galectin science and drug development to create new therapies for fibrotic disease and cancer. Drug candidates based on our unique carbohydrate technology target galectin proteins, which are key mediators of biologic and pathologic function.

Galectin Therapeutics is pursuing therapies for indications in which galectins have a demonstrated role in the pathogenesis of a particular disease. We focus on diseases with serious, life-threatening consequences to patients, and those where current treatment options are limited. Our strategy is to establish clinical development approaches that add value to the Company in the shortest time possible, and to seek partners as the program advances and requires much greater resources.

Galectin Therapeutics leverages extensive scientific and development expertise as well as established relationships with outside sources to achieve cost effective and efficient development. We are pursuing a clear development pathway to clinical enhancement and commercialization for our lead compounds in liver fibrosis and cancer immunotherapy.
 

Galectin Therapeutics is pursuing therapies for indications in which galectins have a demonstrated role in the pathogenesis of a particular disease. We focus on diseases with serious, life-threatening consequences to patients, and those where current treatment options are limited. Though we do not have any current marketed products, our research and development programs, designed to ultimately help patients and their physicians, are focused on:

 

Fibrosis

 

Fibrosis is the development of excess fibrous connective tissue in an organ when exposed to a chronic disease. The longer the disease affects the organ, the more fibrous tissue is deposited and this ultimately results in the failure of the organ. Galectin Therapeutics’ drug candidates provide a promising and exciting new approach for the treatment of fibrotic diseases, including liver, lung and kidney fibrosis. Significant unmet need exists for treatment options in fibrosis. For example, there are currently no approved medical treatments available for the millions of patients in the U.S. who have non-alcoholic steatohepatitis with advanced fibrosis – commonly known as fatty liver disease. Learn about fibrosis and our research in this area including galectin effects on liver fibrosis, lung fibrosis and kidney fibrosis.

 

Cancer

 

Cancer harms the body when damaged cells divide uncontrollably to form lumps or masses of tissue called tumors. Research shows the potential for galectin inhibition to play an important role in cancer therapy, particularly tumor immunotherapy – an emerging treatment that enhances the activity of the immune system against cancer cells. There are more than 100 types of cancers, and for many of these cancers, few treatment options exist. Our drug candidates provide a new and complimentary approach to other drugs on the market for the treatment of cancer. Learn more about cancer and immunotherapy.

 

PostSubject
#653  Sticky Note For those interested in the science of the Darwinian 03/14/14 05:57:24 PM
#1119   Good article--very pro GALT Darwinian 07/24/14 10:56:47 AM
#1118   The last "around the end of March" was IRAHopeful 07/23/14 11:28:04 AM
#1117   I think that we are getting to a thefamilyman 07/23/14 12:18:36 AM
#1116   D, I dont know how perplexing it might 123tom 07/18/14 07:44:17 PM
#1115   Try not to worry about the day to DirectionalDriller 07/18/14 11:44:17 AM
#1114   Given the amount of promotion that the company thefamilyman 07/17/14 01:53:16 PM
#1113   Pretty poor performance today. Could this be a Darwinian 07/17/14 11:54:46 AM
#1112   I saw the La Jolla news after I IRAHopeful 07/16/14 03:43:18 PM
#1111   I got hung up on the turn of Darwinian 07/15/14 10:08:25 PM
#1110   Hah! I admit to doing a double nsomniyak 07/15/14 09:45:26 PM
#1109   Brief history as I remember: IRAHopeful 07/15/14 12:35:04 PM
#1107   Galt's is NOT TOXIC at all, at least Adi2 07/14/14 04:16:00 PM
#1106   History of these drugs. Darwinian 07/14/14 09:46:44 AM
#1105   the you go family man Dynarod 07/14/14 09:27:19 AM
#1104   Please post a link to the source article. thefamilyman 07/14/14 08:58:32 AM
#1103   didn't realise we had some competition using same Dynarod 07/14/14 07:20:39 AM
#1100   Thanks. I've been wondering about this too. I think Darwinian 07/13/14 12:37:25 PM
#1099   Galectin Therapeutics Inc. [$GALT] due diligence stocktrademan 07/13/14 11:14:58 AM
#1098   Nice communication Family man.... well done.and thanks. 123tom 07/13/14 01:42:48 AM
#1097   I used the contact function on the company thefamilyman 07/13/14 12:43:40 AM
#1096   Little blurb about GALT and Fastrack. Darwinian 07/11/14 12:11:22 PM
#1095   Who is bid blocking here? tradervader 07/10/14 12:00:17 PM
#1093   No he hasn't. Anyone foolish enough to biotech2010 07/08/14 02:20:22 PM
#1092   You have been AMAZINGLY accurate with GALT. thefamilyman 07/08/14 01:53:12 PM
#1091   are you watching the price action? 123tom 07/08/14 01:27:34 PM
#1090   maybe the weekly chart also offers a clue 123tom 07/07/14 02:06:32 PM
#1089   and no sooner than the next trading 123tom 07/07/14 01:49:32 PM
#1088   Write up in Motley Fool today. IRAHopeful 07/03/14 02:12:12 PM
#1086   "Think left and think right and think low JERZYATP1 07/01/14 01:38:33 PM
#1085   Intraday price action is doing important things now. 123tom 06/30/14 02:28:23 PM
#1084   well, like I said in a past post...its 123tom 06/30/14 01:35:28 PM
#1083   And because of your previous cautionary statements about thefamilyman 06/30/14 01:17:33 PM
#1082   @ familyman.... 123tom 06/30/14 01:10:34 PM
#1081   I was not optimistic that the Russell rebalancing thefamilyman 06/30/14 12:55:37 PM
#1080   Whats happening now today for GALT ? 123tom 06/30/14 12:44:28 PM
#1079   @ Darwin....interesting blog .thanks for that link. 123tom 06/30/14 03:59:25 AM
#1078   2.25M shares AH RealGenius 06/29/14 02:08:39 AM
#1077   Came across this today. It's interesting to me, Darwinian 06/28/14 10:28:27 PM
#1076   Agreed. GALT was around $5 a year nsomniyak 06/28/14 10:28:31 AM
#1075   Google Russell reballancing effect. You will find it Adi2 06/28/14 06:50:28 AM
#1074   That is one possibility. I discussed some nsomniyak 06/27/14 11:19:15 PM
#1073   What seems to happen is that the funds biotech2010 06/27/14 11:08:11 PM
#1072   got it . thanks. 123tom 06/27/14 10:04:28 PM
#1071   The volume RIGHT AT the close could be nsomniyak 06/27/14 09:53:04 PM
#1070   If somebody can answer this,about the big volume 123tom 06/27/14 08:58:47 PM
#1069   volume for today 2,634,205. For sure some type DirectionalDriller 06/27/14 07:04:48 PM
#1068   Volume reads over 2.5 million now, I think. Darwinian 06/27/14 05:03:07 PM
#1067   All of the Market on Close buys are biotech2010 06/27/14 04:29:42 PM
#1066   $14.15, about 30 cents higher than the share biotech2010 06/27/14 04:12:31 PM
#1065   Yep, 14.15 on Schwab platform at 123tom 06/27/14 04:07:20 PM
PostSubject